BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9878435)

  • 1. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus.
    Menssen R; Orth P; Ziegler A; Saenger W
    J Mol Biol; 1999 Jan; 285(2):645-53. PubMed ID: 9878435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential tapasin dependence of MHC class I molecules correlates with conformational changes upon peptide dissociation: a molecular dynamics simulation study.
    Sieker F; Straatsma TP; Springer S; Zacharias M
    Mol Immunol; 2008 Aug; 45(14):3714-22. PubMed ID: 18639935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501.
    Smith KJ; Reid SW; Stuart DI; McMichael AJ; Jones EY; Bell JI
    Immunity; 1996 Mar; 4(3):203-13. PubMed ID: 8624811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and structural impact of natural polymorphism in the HLA-A3 superfamily.
    Li L; Bouvier M
    Mol Immunol; 2005 Jul; 42(11):1331-44. PubMed ID: 15950729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Several HLA alleles share overlapping peptide specificities.
    Sidney J; del Guercio MF; Southwood S; Engelhard VH; Appella E; Rammensee HG; Falk K; Rötzschke O; Takiguchi M; Kubo RT
    J Immunol; 1995 Jan; 154(1):247-59. PubMed ID: 7527812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
    Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
    Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues.
    Schönbach C; Ibe M; Shiga H; Takamiya Y; Miwa K; Nokihara K; Takiguchi M
    J Immunol; 1995 Jun; 154(11):5951-8. PubMed ID: 7751638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site.
    Collins EJ; Garboczi DN; Wiley DC
    Nature; 1994 Oct; 371(6498):626-9. PubMed ID: 7935798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
    Barber LD; Percival L; Arnett KL; Gumperz JE; Chen L; Parham P
    J Immunol; 1997 Feb; 158(4):1660-9. PubMed ID: 9029102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling of an antigenic complex between a viral peptide and a class I major histocompatibility glycoprotein.
    Rognan D; Reddehase MJ; Koszinowski UH; Folkers G
    Proteins; 1992 May; 13(1):70-85. PubMed ID: 1594579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-B15 peptide ligands are preferentially anchored at their C termini.
    Prilliman KR; Jackson KW; Lindsey M; Wang J; Crawford D; Hildebrand WH
    J Immunol; 1999 Jun; 162(12):7277-84. PubMed ID: 10358176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs.
    Harris PE; Colovai A; Liu Z; Dalla Favera R; Suciu-Foca N
    J Immunol; 1993 Dec; 151(11):5966-74. PubMed ID: 8245441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
    Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
    J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of MHC class I molecules with bound peptide antigens.
    Wilson IA; Fremont DH
    Semin Immunol; 1993 Apr; 5(2):75-80. PubMed ID: 8504218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.